Paolo Manfredi & Marco Pappagallo - REL-1017 (esmethadone hydrochloride) a novel uncompetitive...

Sdílet
Vložit
  • čas přidán 2. 10. 2022
  • REL-1017 (esmethadone hydrochloride) a novel uncompetitive NMDAR antagonist with a preference for NR1-NR2D subtypes shows rapid, robust, and sustained antidepressant effects as adjunctive treatment for MDD
  • Věda a technologie

Komentáře •